Intellia Therapeutics Inc buy Wolfe Research
Start price
21.04.25
/
50%
€6.94
Target price
21.04.26
€18.30
Performance (%)
58.33%
Price
18:39
€10.99
Summary
This prediction is currently active. The BUY prediction by Wolfe_Research for Intellia Therapeutics Inc has seen massive gains of 58.33%. This prediction currently runs until 21.04.26. The prediction end date can be changed by Wolfe_Research at any time. Wolfe_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | -3.393% | -3.393% |
| iShares Core DAX® | -3.509% | -8.747% |
| iShares Nasdaq 100 | -2.782% | -0.632% |
| iShares Nikkei 225® | -2.038% | -6.841% |
| iShares S&P 500 | -2.598% | -2.230% |
Comments by Wolfe_Research for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $21.00 price target on the stock.
Ratings data for NTLA provided by MarketBeat